Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.

CONCLUSION: A patient-tailored CIM program, initiated within a week of the first chemotherapy cycle, may help reduce the severity of fatigue, depression, and impaired well-being among patients with breast and gynecological cancers. PMID: 29980837 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29980837?dopt=Abstract

Source: Clinical Breast Cancer - July 6, 2018 Category: Cancer & Oncology Authors: Ben-Arye E, Dahly H, Keshet Y, Dagash J, Samuels N Tags: J Cancer Res Clin Oncol Source Type: research